IL102381A0 - Pharmaceutical compositions containing benzimidazoline-2-oxo-1-carboxylic acid derivatives for the treatment of organic mental diseases - Google Patents
Pharmaceutical compositions containing benzimidazoline-2-oxo-1-carboxylic acid derivatives for the treatment of organic mental diseasesInfo
- Publication number
- IL102381A0 IL102381A0 IL102381A IL10238192A IL102381A0 IL 102381 A0 IL102381 A0 IL 102381A0 IL 102381 A IL102381 A IL 102381A IL 10238192 A IL10238192 A IL 10238192A IL 102381 A0 IL102381 A0 IL 102381A0
- Authority
- IL
- Israel
- Prior art keywords
- benzimidazoline
- oxo
- treatment
- carboxylic acid
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI911845A IT1250629B (it) | 1991-07-04 | 1991-07-04 | Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL102381A0 true IL102381A0 (en) | 1993-01-14 |
Family
ID=11360276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL102381A IL102381A0 (en) | 1991-07-04 | 1992-07-02 | Pharmaceutical compositions containing benzimidazoline-2-oxo-1-carboxylic acid derivatives for the treatment of organic mental diseases |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0523013B1 (xx) |
| JP (1) | JPH05194216A (xx) |
| KR (1) | KR930001906A (xx) |
| AT (1) | ATE115857T1 (xx) |
| AU (1) | AU658197B2 (xx) |
| CA (1) | CA2072911A1 (xx) |
| DE (1) | DE69200948T2 (xx) |
| DK (1) | DK0523013T3 (xx) |
| GR (1) | GR3015413T3 (xx) |
| HU (2) | HUT61462A (xx) |
| IE (1) | IE922174A1 (xx) |
| IL (1) | IL102381A0 (xx) |
| IT (1) | IT1250629B (xx) |
| MX (1) | MX9203900A (xx) |
| NO (1) | NO922635L (xx) |
| TW (1) | TW202386B (xx) |
| ZA (1) | ZA924949B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05310732A (ja) * | 1992-03-12 | 1993-11-22 | Mitsubishi Kasei Corp | シンノリン−３−カルボン酸誘導体 |
| JP2699794B2 (ja) * | 1992-03-12 | 1998-01-19 | 三菱化学株式会社 | チエノ〔３，２−ｂ〕ピリジン誘導体 |
| AU1734401A (en) * | 1999-12-09 | 2001-06-18 | Mitsubishi Pharma Corporation | Carboxyamido derivatives |
| CA2601458C (en) | 2005-03-15 | 2011-04-26 | Pfizer Inc. | Benzimidazolone derivatives as cb2 receptor ligands |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4605652A (en) * | 1985-02-04 | 1986-08-12 | A. H. Robins Company, Inc. | Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes |
| EP0551963A3 (en) * | 1986-12-17 | 1993-09-01 | Glaxo Group Limited | Use of heterocyclic derivatives for the manufacture of medicaments |
| IT1231413B (it) * | 1987-09-23 | 1991-12-04 | Angeli Inst Spa | Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht |
| US4887422A (en) * | 1988-09-06 | 1989-12-19 | Amsted Industries Incorporated | Rope with fiber core and method of forming same |
-
1991
- 1991-07-04 IT ITMI911845A patent/IT1250629B/it active IP Right Grant
-
1992
- 1992-07-02 AU AU19381/92A patent/AU658197B2/en not_active Ceased
- 1992-07-02 DE DE69200948T patent/DE69200948T2/de not_active Expired - Fee Related
- 1992-07-02 DK DK92830346.0T patent/DK0523013T3/da active
- 1992-07-02 EP EP92830346A patent/EP0523013B1/en not_active Expired - Lifetime
- 1992-07-02 TW TW081105256A patent/TW202386B/zh active
- 1992-07-02 AT AT92830346T patent/ATE115857T1/de not_active IP Right Cessation
- 1992-07-02 CA CA002072911A patent/CA2072911A1/en not_active Abandoned
- 1992-07-02 MX MX9203900A patent/MX9203900A/es unknown
- 1992-07-02 JP JP4175281A patent/JPH05194216A/ja active Pending
- 1992-07-02 IL IL102381A patent/IL102381A0/xx unknown
- 1992-07-03 NO NO92922635A patent/NO922635L/no unknown
- 1992-07-03 IE IE217492A patent/IE922174A1/en not_active Application Discontinuation
- 1992-07-03 KR KR1019920011823A patent/KR930001906A/ko not_active Application Discontinuation
- 1992-07-03 HU HU9202229A patent/HUT61462A/hu unknown
- 1992-07-03 ZA ZA924949A patent/ZA924949B/xx unknown
-
1995
- 1995-03-13 GR GR950400566T patent/GR3015413T3/el unknown
- 1995-06-30 HU HU95P/P00716P patent/HU211855A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI911845A1 (it) | 1993-01-05 |
| AU658197B2 (en) | 1995-04-06 |
| TW202386B (xx) | 1993-03-21 |
| JPH05194216A (ja) | 1993-08-03 |
| KR930001906A (ko) | 1993-02-22 |
| IT1250629B (it) | 1995-04-21 |
| HUT61462A (en) | 1993-01-28 |
| NO922635D0 (no) | 1992-07-03 |
| HU9202229D0 (en) | 1992-10-28 |
| EP0523013A2 (en) | 1993-01-13 |
| CA2072911A1 (en) | 1993-01-05 |
| DE69200948D1 (de) | 1995-02-02 |
| GR3015413T3 (en) | 1995-06-30 |
| ATE115857T1 (de) | 1995-01-15 |
| AU1938192A (en) | 1993-01-07 |
| HU211855A9 (en) | 1995-12-28 |
| DK0523013T3 (da) | 1995-05-08 |
| NO922635L (no) | 1993-01-05 |
| MX9203900A (es) | 1993-01-01 |
| ITMI911845A0 (it) | 1991-07-04 |
| EP0523013B1 (en) | 1994-12-21 |
| DE69200948T2 (de) | 1995-05-18 |
| ZA924949B (en) | 1994-01-03 |
| IE922174A1 (en) | 1993-01-13 |
| EP0523013A3 (en) | 1993-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA928170B (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid | |
| AU637086B2 (en) | Use of 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in the preparation of pharmaceutical compositions in controlled- release form active in the therapy of organic mental disturbances, and the relative pharmaceutical compositions | |
| NZ240936A (en) | Alkoxy-substituted 1-phenyl-isoquinoline derivative and pharmaceutical compositions | |
| IL104006A0 (en) | Azaheterocyclylmethyl-chromans,their preparation and pharmaceutical compositions containing them | |
| IL109578A (en) | Nor-bile acid derivatives processes for their preparation and the use of these compounds as medicaments | |
| GR3023638T3 (en) | Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs | |
| ZA885192B (en) | Pharmaceutical preparations | |
| NZ218028A (en) | Benzimidazole derivatives and pharmaceutical compositions | |
| IL94819A0 (en) | 11beta-aryl-4-estrene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| ZA881561B (en) | Substituted pyridine-2,4-dicarboxylic acid derivatives,processes for their preparation,the use thereof and medicaments based on these compounds | |
| ZA924949B (en) | New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives | |
| EP0535250A4 (en) | Novel compounds and use thereof as medicine | |
| IL89335A (en) | 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds | |
| TW218011B (xx) | ||
| IL106289A0 (en) | Phospholipid derivatives, their preparation and pharmaceutical compositions containing them | |
| IL99666A0 (en) | Pharmaceutical compositions for the treatment of diabetes | |
| NZ223333A (en) | 3-phenyl-7h-thiazole (3,2-b (1,2, triazin-7-one derivatives and pharmaceutical compositions | |
| NO163283C (no) | Analogifremgangsm te til fremstilling av terapeutisk aktive n-bicykloheptyl og n-bicykloheptenylimidazoler. |